GlaxoSmithKline reported 8.8B in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Abbvie ABBV:US $ 10733M 756M
Alcon AG ALC:SW 1.87B 83M
Amgen AMGN:US $ 5077M 182M
Artemis Alpha ATS:LN 2.51M 1.66M
AstraZeneca AZN:LN 9.05B 1.26B
Bayer BAYN:GR 17.82B 4.54B
Biogen BIIB:US $ 2021.4M 59.7M
Bristol Myers Squibb BMY:US $ 8511M 858M
Eli Lilly And LLY:US $ 7805.7M 321.5M
Fresenius FRE:GR € 7983M 791M
Fresenius Medical Care FME:GR € 3890.82M 319.4M
Galapagos GLPG:NA 78.52M 49.64M
Genmab GEN:DC 3.19B 211M
Gilead Sciences GILD:US $ 3787M 706M
GlaxoSmithKline GSK:LN 8.8B 451M
Glaxosmithkline GSK:US $ 8797M 451M
GRIFOLS GRF:SM € 644.7M 148.92M
H. Lundbeck A/S LUN:DC 3.91B 354M
Hikma Pharmaceutical HIK:LN 811M 31M
Merck MRK:GR € 4705M 360M
Merk MRK:US $ 9828M 598M
Novartis NOVN:VX 8.68B 395M
Orion ORNBV:FH 212.1M 3.7M
Recordati REC:IM 407.68M 55.02M
Regeneron Pharmaceuticals REGN:US $ 4839M 1197.5M